SPLRFPHOTOS206905
splrfphotos206905
X
![](https://www.newscom.com/zh/creative-search?p_p_id=listenersearchresults_WAR_searchportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_cacheability=cacheLevelPage&p_p_col_id=column-2&p_p_col_count=1&_listenersearchresults_WAR_searchportlet_struts.portlet.action=%2Fview%2Fwmark&_listenersearchresults_WAR_searchportlet_inputPath=/db/SPL/splrfphotos/docs/206/905.thm&tagId=splrfphotos206905&size=512" alt="splrfphotos206905)
Illustration of a proteolysis-targeting chimera (PROTAC) molecule (orange) in complex with Brd4 (dark blue) and pVHL:ElonginC:ElonginB (light blue). PROTACs are small molecules consisting of two ligand compounds joined by a linker that enable the targeted degradation of a protein of interest.
Post Date:
Apr 26, 2024 9:29 PM
TAG ID:
splrfphotos206905 (RF)
Credit:
THOM LEACH / SCIENCE PHOTO LIBRARY/Newscom
Format:
6000 x 3375 Color JPEG
Photographer:
THOM LEACH / SCIENCE PHOTO LIBRARY
Keywords:
medicine, medical, pharmaceutical, pharmacology, drug, treatment, protac, proteolysis, targeting, chimera, targeted, protein, degrader, protein, degradation, small, molecule, drug, novel, drug, blue, background, chemotherapy, cgi, digitally-generated, 3d, three, dimensional, artwork, illustration, nobody, no-one, white, background
Release Status:
No Model Release, No Property Release
Please submit a licensing request for pricing on this usage.
